3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Leukemia, Myeloid, Accelerated Phase
3
Down Syndrome
3
Blast Crisis
3
Osteosarcoma
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Urothelial Carcinoma of the Bladder
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Interventions
piperine
1
Curcumin
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Monoclonal Gammopathy of Undetermined Significance
×
Methotrexate
×
30 days
×
Clear all
No trials found.